Eilis Quinn

Eilis has significant General Management and start up experience. She is a senior commercial professional with strong leadership experience in the healthcare industry including diverse global markets and therapeutic areas and a solid track record of building and leading commercial strategy and teams.

Eilis is currently the General Manager of Australia and New Zealand for Jazz Pharmaceuticals, an international pharmaceutical company specializing in oncology and neuroscience. Prior to commencing with Jazz, Eilis’ previous role was Senior Director of the Global Pipeline Division for Vertex Pharmaceuticals based in Boston, where she co-led the global commercial team to determine the long term global business strategy through assessment of global market opportunities. Before this role, Eilis was Managing Director for Vertex Pharmaceuticals for Australia and New Zealand. She led and developed the market entry business plans and executed the reimbursement strategy in order to launch multiple products and indications.

Prior to these roles Eilis also held a variety of senior roles in global biotechnology companies. She managed product launches in Europe, CEE, Middle East and APAC regions.

Eilis has a Master of Arts (MA) Biotechnology, Law and Ethics, from the University of Sheffield, a Master of Science (MSc) Biomedical Sciences, University of Westminster, London, UK and a Bachelor of Science (BSc) Biomedical Sciences, from University of Ulster, Ireland.